FINANCIALS

TARS Tarsus Pharmaceuticals Inc 1819790

Income Statement
Revenue	tars-20241231	182,953,000
Net Income	tars-20241231	-115,554,000
Profit Margin		-63.16%

Balance Sheet
Current Assets	356,705,000
Assets	376,991,000
Current Liabilities	80,612,000
Liabilities	152,457,000
Equity	224,534,000
Shares Out	38,042,000

Cash Flow Statement
Operating Cash Flow	-83,027,000
Investing Cash Flow	-199,195,000

Market Analysis
Market Cap	1,183,478,243
Price	50.02
BVPS	5.90
PB	8.25
EPS	-4.43
PS	1.62
FCF	-282,222,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view TARS documents filed with the SEC.

TARS Filings Clear

View A List of Tickers